Recombinant Human VASH1 Protein，His

VASH1 (Vasohibin-1) is an angiogenic factor that plays a crucial role in the regulation of blood vessel formation and maintenance. It was originally identified for its ability to inhibit endothelial cell proliferation and migration, processes essential for angiogenesis. The significance of VASH1 in vascular biology has led to extensive research into its potential roles in various physiological and pathological conditions, including cancer, ischemic diseases, and wound healing. Emerging studies have highlighted its dual functions, not only as an anti-angiogenic protein but also as a promoter of endothelial cell survival and differentiation in specific contexts. Understanding the molecular mechanisms underlying VASH1’s action could provide insights into novel therapeutic strategies for diseases characterized by abnormal angiogenesis. Furthermore, the recombinant expression of VASH1 has enabled researchers to explore its functional properties in controlled environments, facilitating investigations into its interactions with endothelial cells and other cell types. Characterizing VASH1’s structure and function through recombinant protein studies can pave the way for the development of targeted therapies that manipulate angiogenesis for clinical benefit. These efforts underscore the importance of VASH1 as a potential biomarker and therapeutic target in angiogenesis-related diseases.